Published June 2, 2026
| Version v1
Other
Open
What evidence supports biological therapy, aside from anti-TNF therapy, for ileal Crohn's disease with perianal disease?
Description
While anti-TNF therapy is a mainstay for Crohn's disease, other biological treatments such as ustekinumab, guselkumab, mirikizumab, and upadacitinib show promise for Ileal Crohn's disease with perianal involvement.
Files
b16ebccc-91a2-4164-96c5-984a41c2d7a6.pdf
Files
(18.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:bed7354bf8226dd4fc77f8bb49a09d65
|
18.5 kB | Preview Download |